These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 792846)

  • 1. The clinical problems of dosage and the route of administration of antilymphocyte globulin.
    Barnes AD; Sansom JR
    Postgrad Med J; 1976; 52(5 Suppl):39-40. PubMed ID: 792846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 3. [The clinical use of antilymphocyte globulin (ALG) (author's transl)].
    Brendel W; Seifert J; Ring J
    MMW Munch Med Wochenschr; 1975 Aug; 117(35):1361-8. PubMed ID: 809676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiation of ALG pretransplant reduces the incidence of delayed renal allograft function.
    Hong JH; Sumrani N; Cacciarelli TV; Distant D; Sommer BG
    Transplant Proc; 1993 Feb; 25(1 Pt 1):581-2. PubMed ID: 8438423
    [No Abstract]   [Full Text] [Related]  

  • 5. A randomized prospective clinical trial of antilymphocyte globulin in 100 cadaveric renal transplants.
    Sansom JR; Barnes AD; Hall CL
    Postgrad Med J; 1976; 52(5 Suppl):75-8. PubMed ID: 792851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular damage after intravenous administration of antilymphocyte globulin (ALG) in man and rhesus monkeys.
    Moppert J; Thiel G; Mahlich J; Bühler F; Vischer T; Enderlin F; Weber H; Zollinger HU
    Transplant Proc; 1971 Mar; 3(1):741-4. PubMed ID: 4999468
    [No Abstract]   [Full Text] [Related]  

  • 7. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation.
    Nestor ZJ; Rocher LL; Merion RM; Swartz RD; Turcotte JG; Campbell DA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG; Henry ML; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract]   [Full Text] [Related]  

  • 9. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality control of thrombogenic properties of clinical ALG.
    Thomas T; Thomas F; Mauer H; Caul J; Lee HM
    Proc Clin Dial Transplant Forum; 1973; 3():69-73. PubMed ID: 4619687
    [No Abstract]   [Full Text] [Related]  

  • 11. Nursing review of the use and administration of antilymphocyte globulin in renal transplantation.
    Downs SA
    J Am Assoc Nephrol Nurses Tech; 1981 Feb; 8(1):49-51. PubMed ID: 7009705
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacodynamics of antilymphocyte globulin (ALG) in mice with skin allotransplants. I. Distribution and elimination of ALG-I-131 during single and multiple administration].
    Serebriakov NG; Suskova VS; Petrosova VN; Emets VI; Skriabina EG
    Vestn Akad Med Nauk SSSR; 1973; 28(8):77-81. PubMed ID: 4585260
    [No Abstract]   [Full Text] [Related]  

  • 13. Antilymphocyte globulin and renal transplantation.
    Tagnon A
    Postgrad Med J; 1976; 52(5 Suppl):64-6. PubMed ID: 792848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical factors in the quality control of antilymphocyte globulin (ALG).
    Thomas F; Thomas J; Millington G; Doane J; Mendez-Picon G; Lee HM
    Proc Clin Dial Transplant Forum; 1977; 7():134-40. PubMed ID: 98763
    [No Abstract]   [Full Text] [Related]  

  • 15. Past experience and future studies with antilymphocyte globulin in recipients of kidney homografts.
    Putnam CW; Bell RH; Beart RW; Anderson JT; Weil R
    Postgrad Med J; 1976; 52(5 Suppl):59-63. PubMed ID: 792847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of long term combined imuran ALG dosage.
    Ollodart RM; Flotte CT; Lubash GD; Young JD; Sadler JH; Ramos E
    Proc Clin Dial Transplant Forum; 1972; 2():8-16. PubMed ID: 4219814
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
    Venkat KK; Kupin W; Oh HK
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
    [No Abstract]   [Full Text] [Related]  

  • 18. Antilymphocyte globulin with a small dose of cyclosporine A and prednisone as the induction of immunosuppression in renal allograft recipients.
    Boratyńska M; Szepietowski T; Szewczyk Z; Szydłowski Z
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):163-8. PubMed ID: 1299176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency and maintenance in antilymphocyte globulin fractionation: contrasting tests of effectiveness in an animal model.
    Salerni B; Simmonian SJ; Kay RG; Latham WC; Brown KJ; Birtch AG; Busch GJ; Lukl P; Woods JE
    Surg Forum; 1970; 21():277-9. PubMed ID: 4936983
    [No Abstract]   [Full Text] [Related]  

  • 20. Development, production and quality control of clinically applied antilymphocyte globulin.
    Seiler FR
    Postgrad Med J; 1976; 52(5 Suppl):II-19. PubMed ID: 825843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.